Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient
Status:
Recruiting
Trial end date:
2021-08-30
Target enrollment:
Participant gender:
Summary
Determine the efficacy and safety of COVID19-0001-USR in the treatment of SARS-COV-2
infection in mild to moderate manifestations administered via nebulization/inhalation.